| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mass treatment to eliminate filariasis in Papua New Guinea.
|
N Engl J Med
|
2002
|
4.23
|
|
2
|
Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations.
|
Nat Med
|
2002
|
3.29
|
|
3
|
Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.
|
J Immunol
|
2004
|
2.32
|
|
4
|
Mathematical modelling and the control of lymphatic filariasis.
|
Lancet Infect Dis
|
2004
|
2.13
|
|
5
|
Why do we need to know more about mixed Plasmodium species infections in humans?
|
Trends Parasitol
|
2004
|
1.98
|
|
6
|
Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis.
|
Am J Trop Med Hyg
|
2006
|
1.93
|
|
7
|
The role of animal models for research on severe malaria.
|
PLoS Pathog
|
2012
|
1.76
|
|
8
|
The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
|
PLoS Negl Trop Dis
|
2008
|
1.74
|
|
9
|
Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea.
|
Am J Trop Med Hyg
|
2002
|
1.73
|
|
10
|
Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs.
|
Am J Trop Med Hyg
|
2008
|
1.70
|
|
11
|
Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
|
Am J Trop Med Hyg
|
2005
|
1.70
|
|
12
|
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2008
|
1.50
|
|
13
|
Insecticidal bed nets and filariasis transmission in Papua New Guinea.
|
N Engl J Med
|
2013
|
1.48
|
|
14
|
Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.
|
PLoS One
|
2008
|
1.46
|
|
15
|
Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes.
|
PLoS One
|
2007
|
1.45
|
|
16
|
Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
|
J Immunol
|
2007
|
1.44
|
|
17
|
Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.
|
J Infect Dis
|
2007
|
1.39
|
|
18
|
Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
|
Trends Parasitol
|
2006
|
1.39
|
|
19
|
Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus.
|
J Immunol
|
2002
|
1.32
|
|
20
|
Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.
|
J Infect Dis
|
2008
|
1.32
|
|
21
|
Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood.
|
J Infect Dis
|
2006
|
1.31
|
|
22
|
Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya.
|
Infect Immun
|
2003
|
1.29
|
|
23
|
Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.
|
Infect Immun
|
2004
|
1.27
|
|
24
|
Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands.
|
Infect Immun
|
2005
|
1.26
|
|
25
|
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.
|
Am J Trop Med Hyg
|
2008
|
1.25
|
|
26
|
Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions.
|
Trends Parasitol
|
2006
|
1.20
|
|
27
|
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.
|
Infect Immun
|
2008
|
1.17
|
|
28
|
Mass chemotherapy options to control lymphatic filariasis: a systematic review.
|
Lancet Infect Dis
|
2005
|
1.13
|
|
29
|
Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in Kenya.
|
Infect Immun
|
2003
|
1.12
|
|
30
|
Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes.
|
PLoS One
|
2008
|
1.08
|
|
31
|
Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy.
|
J Immunol
|
2006
|
1.07
|
|
32
|
A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes.
|
Am J Trop Med Hyg
|
2007
|
1.05
|
|
33
|
Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New Guinea.
|
Filaria J
|
2003
|
1.04
|
|
34
|
Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission.
|
Am J Trop Med Hyg
|
2002
|
1.04
|
|
35
|
Lymphatic filariasis in Papua New Guinea: prospects for elimination.
|
Med Microbiol Immunol
|
2002
|
1.03
|
|
36
|
Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea.
|
Am J Hematol
|
2004
|
1.03
|
|
37
|
The complete mitochondrial genome sequence of the filarial nematode Wuchereria bancrofti from three geographic isolates provides evidence of complex demographic history.
|
Mol Biochem Parasitol
|
2012
|
1.03
|
|
38
|
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area.
|
Am J Trop Med Hyg
|
2006
|
1.01
|
|
39
|
Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
|
Pediatr Infect Dis J
|
2011
|
1.01
|
|
40
|
Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.
|
Malar J
|
2009
|
1.00
|
|
41
|
TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria.
|
Am J Trop Med Hyg
|
2010
|
1.00
|
|
42
|
Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1.
|
PLoS One
|
2011
|
1.00
|
|
43
|
Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya.
|
Pediatr Infect Dis J
|
2005
|
0.99
|
|
44
|
Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites.
|
J Infect Dis
|
2013
|
0.99
|
|
45
|
The dynamics of naturally acquired immunity to Plasmodium falciparum infection.
|
PLoS Comput Biol
|
2012
|
0.97
|
|
46
|
Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections.
|
Am J Trop Med Hyg
|
2010
|
0.94
|
|
47
|
Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control.
|
Adv Parasitol
|
2007
|
0.93
|
|
48
|
Back to the future: the American Society of Tropical Medicine and Hygiene, its journal and the continuing commitment to global health.
|
Am J Trop Med Hyg
|
2011
|
0.93
|
|
49
|
Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.
|
Proc Biol Sci
|
2010
|
0.92
|
|
50
|
Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea.
|
Am J Trop Med Hyg
|
2007
|
0.91
|
|
51
|
Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya.
|
Malar J
|
2003
|
0.89
|
|
52
|
Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya.
|
Am J Trop Med Hyg
|
2009
|
0.89
|
|
53
|
Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.
|
Infect Immun
|
2010
|
0.89
|
|
54
|
Erythrocyte polymorphisms and malaria parasite invasion in Papua New Guinea.
|
Trends Parasitol
|
2003
|
0.89
|
|
55
|
Toll-like receptor polymorphisms in malaria-endemic populations.
|
Malar J
|
2009
|
0.87
|
|
56
|
Advances in Rift Valley fever research: insights for disease prevention.
|
Curr Opin Infect Dis
|
2010
|
0.87
|
|
57
|
Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
|
PLoS Negl Trop Dis
|
2011
|
0.86
|
|
58
|
Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.
|
J Infect Dis
|
2013
|
0.82
|
|
59
|
Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study.
|
Malar J
|
2012
|
0.82
|
|
60
|
Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New Guinea.
|
Am J Trop Med Hyg
|
2012
|
0.82
|
|
61
|
Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection.
|
Malar J
|
2012
|
0.81
|
|
62
|
Time-to-infection by Plasmodium falciparum is largely determined by random factors.
|
BMC Med
|
2015
|
0.79
|
|
63
|
Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population.
|
Am J Trop Med Hyg
|
2013
|
0.78
|
|
64
|
Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history.
|
PLoS Negl Trop Dis
|
2013
|
0.78
|
|
65
|
Malaria vaccines: into a mirror, darkly?
|
Trends Parasitol
|
2008
|
0.77
|
|
66
|
Higher-dose, more frequent treatment of Wuchereria bancrofti.
|
Clin Infect Dis
|
2010
|
0.77
|
|
67
|
Sensitivity and specificity of ultrasound detection and risk factors for filarial-associated hydroceles.
|
Am J Trop Med Hyg
|
2003
|
0.77
|
|
68
|
Elimination of lymphatic filariasis.
|
Lancet
|
2006
|
0.76
|